The synergistic effect of Landolphia owariensis latex and Eudragit® L-100-coated capsules on the in vitro controlled release of metronidazole for possible colon targeting

Asian Journal of Pharmaceutics

Volumn 5, Issue 2, 2011, Pages 75-83

  Obitte, Nicholas C ^a   Chukwu, Amarauche ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Capsule surface coating; colon targeting; dissolution medium; drug release kinetics; metronidazole

Indexed keywords

EUDRAGIT; LATEX; METRONIDAZOLE;

AMEBIC INFECTION; ARTICLE; COLON; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TARGETING; ENCAPSULATION; GRANULATION TISSUE; IN VITRO STUDY; LANDOLPHIA OWARIENSIS; PARTICLE SIZE; PH;

EID: 80052881474     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.84547     Document Type: Article

References (42)

1. Toshikiro K, Kazutaka H. Gastrointestinal transit and drug absorption. Biol Pharm Bull 2002;25:149-64.
2. Kshirsagar NA. Drug delivery systems. Indian J Pharmacol 2000;32:S54-61.
3. Gupta VK, Beckert TE, Price JC. A novel pH-and time-based multi-unit potential colonic drug delivery system, I: Development. Int J Pharm 2001;213:83-91. (Pubitemid 32119464)
4. Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, et al. Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech 2006;7:74.
5. Walsh JA. Problems in recognition and diagnosis of amoebiasis: Estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-38.
6. World Health Organization. Amoebiasis. WHO Wkly Epidemiol Record 1997;72:97-100.
7. Nasra MA, EL-Massik MA, Naggar VF. Development of metronidazole colon-specific delivery systems. Asian J Pharm Sci 2007;2:18-28.
8. Martindale. "The Complete Drug Reference". 34th Ed., ed. by Sean C.S., The Pharmaceutical Press; 2005.
9. van den Mooter G, Kinget R. Oral colon-specific drug delivery: A review. Drug Del 1995;2:81-93.
10. Rama Prasad YV, Krishnaiah YS, Satyanarayana S. Trends in colonic drug delivery: A review. Indian Drugs 1996;33:1-10. (Pubitemid 26248119)
11. Obitte NC, Chukwu A, Onyishi VI, Obitte BC. The Physicochemical evaluation and applicability of Landolphia owariensis latex as a release modulating agent in its admixture with Carbosil® in Ibuprofen-loaded self-emulsifying oil formulations. Int J Appl Res Prod 2009;2:27-43.
12. Obitte NC, Chukwu A, Onyishi VI. The use of a pH-dependent and non pH-dependent natural hydrophobic biopolymer (Landolphia owariensis latex) as capsule coating agents in in vitro controlled release of metronidazole for possible colon targeted delivery. Int J Appl Res Prod 2010;2:1-17.
13. Adikwu MU, Ossai AO. Evaluation of Landolphia dulcis pseudolatex as a granulating fluid for aminophylline tablets. Acta Pharma 1994;44:157-62. (Pubitemid 24311384)
14. Obitte NC, Chukwu A. Physicotechnical properties of theophylline capsules prepared with Tacca involucrata starch. West J Pharm 2007;20:23-30.
15. Akhgari A, Garekani HA, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm 2005;305:22-30. (Pubitemid 41562214)
16. Kuksal A, Ashok KT, Narendra KJ, Subheet J. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix Formers. AAPS PharmSciTech 2006;7:E1-9.
17. Ibekwe VC, Kendall RA and Basit AW. Drug delivery to the colon, The Drug Delivery Companies Report, Spring/Summer, Pharmaventures Ltd; 2004.
18. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035-41.
19. Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33. (Pubitemid 32288781)
20. Sreenivas SA, Hiremath SP, Godbole AM. Ofloxacin ocular inserts: Design, formulation and evaluation. Int J Pharm Therap 2006;5:159-62. (Pubitemid 351326221)
21. Korsemeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;25-35. (Pubitemid 13092121)
22. Dubey S, Bajpai SK. Poly (methacrylamide-co-acrylicacid) hydrogels for gastrointestinal delivery of theophylline. I. Swelling characterization. J Appl Pol Sc 2006;101:2995-3008. (Pubitemid 44220936)
23. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation 1: Theoretical consideration. Ind Eng Chem 1931;23:923-31.
24. Pather I, Russell I, Syce JA, Neau SH. Sustained release theophyline tablets by direct compression, Part 1: Formulation and in vitro testing. Int J Pharm 1998;164:1-10. (Pubitemid 28160092)
25. Emami J. In vitro-in vivo correlation: From theory to applications J Pharm Pharmaceut Sci 2006;9:169-89.
26. Steed KP, Clive GW, Washington N. Drug delivery to the large intestine. Physiological Pharmaceutics. England: Ellis Horwood Ltd; 1989. p. 90-107.
27. McCoy JJ, Mann BJ, Petri WA. Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun 1994;62:3045-50. (Pubitemid 24232080)
28. Stilwell GG. Amebiasis: Its early history. Gastroenterology 1955;28:606-22.
29. Petri WA, Clark G, Diamond LS. Host-parasite relationships in amebiasis. J Infect Dis 1994;169:483-84.
30. Ali N, Davoud H, Farnaz M, Nita T. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices. Acta Pharm 2008;58:151-62.
31. Bomba M, Puisieux F, Marty JP Carstensen JT. Release mechanisms in gel forming sustained release preparations. Int J Pharm 1979;2:307-15. (Pubitemid 9161631)
32. Obitte NC, Chukwu A. Dissolution characteristics of theophylline capsules containing Tacca involucrata starch as binder. West Afr J Pharm 2007;20:40-50.
33. Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. In vitro investigation into the suitability of pH dependent polymer for colonic targeting: An in-vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm 1993;95:193-9. (Pubitemid 23203152)
34. Leopold CS, Eikeler D. Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease. Drug Dev Ind Pharm 2000;26:1239-46. (Pubitemid 32037420)
35. Kumar P, Singh S, Mishra B. Colon targeted delivery systems of metronidazole based on osmotic technology: Development and evaluation. Chem Pharm Bull 2008;56,9:1234-42.
36. Abdou HM. Dissolution. Remington: The science and practice of pharmacy. 20th ed. vol.1. In: Limmer D, editor. Philadelphia, USA: Lippincott Williams and Wilkins; 2000.
37. Arshia S, Manna PK, Paranjothy KL, Manjula M. Entrapment of andrographolide in cross-linked alginate pellets: I, formulation and evaluation of associated release kinetics. Pak J Pharm Sci 2007;20:1-9.
38. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-1.
39. Lourdes O, Manuela I, Rosa M, Hernández AR, Gascn JL. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharmaceut Sci 2005;8:132-40.
40. Thombre AG, Cardinal JR, DeNoto AR, Herbig SM, Smith KL. Asymmetric membrane capsule for osmotic drug delivery, I: Development of manufacturing process. J Control Rel 1999;57:55-64.
41. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric membrane tablet coatings for osmotic drug delivery. J Control Rel 1995;35:127-36.
42. Pratim KC, Mahendra SR, Mousumi KP, Chetan SC. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm 2007;57:343-50.